Sylvain Lamure
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 5%
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
Papers in
- Oncology 23
- COVID-19 and healthcare impacts 14
- CAR-T cell therapy research 9
-
- COVID-19 Clinical Research Studies 19
- SARS-CoV-2 and COVID-19 Research 7
- Co-authors
- Guillaume Cartron (8 shared papers)Laura Platon (2 shared papers)Xavier Ayrignac (2 shared papers)Catherine Thiéblemont (1 shared paper)Cathérine Belin (1 shared paper)Perrine Devic (1 shared paper)Rénata Ursu (1 shared paper)Florent Wallet (1 shared paper)
In The Last Decade
Sylvain Lamure
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 59
- Infectious Diseases 684
- Oncology 448
- Hematology 128
- Genetics 47
- Pathology and Forensic Medicine 69
Countries citing papers authored by Sylvain Lamure
This map shows the geographic impact of Sylvain Lamure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Lamure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Lamure more than expected).
Fields of papers citing papers by Sylvain Lamure
This network shows the impact of papers produced by Sylvain Lamure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Lamure. The network helps show where Sylvain Lamure may publish in the future.
Co-authors
The 25 scholars most cited alongside Sylvain Lamure, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 243 | |
| 2 | 2021 | 123 | |
| 3 | 2020 | 94 | |
| 4 | 2021 | 72 | |
| 5 | 2022 | 66 | |
| 6 | 2022 | 63 | |
| 7 | 2021 | 58 | |
| 8 | 2022 | 54 | |
| 9 | 2020 | 48 | |
| 10 | 2020 | 33 | |
| 11 | 2022 | 31 | |
| 12 | 2019 | 30 | |
| 13 | 2021 | 30 | |
| 14 | 2023 | 27 | |
| 15 | 2020 | 22 | |
| 16 | 2021 | 22 | |
| 17 | 2024 | 20 | |
| 18 | 2023 | 19 | |
| 19 | 2024 | 18 | |
| 20 | 2022 | 15 |
About Sylvain Lamure
Sylvain Lamure is a scholar working on Oncology, Infectious Diseases, Hematology, Pathology and Forensic Medicine and Genetics, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (19 papers), COVID-19 and healthcare impacts (14 papers), CAR-T cell therapy research (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Infectious Diseases (684 citations), Oncology (448 citations), Hematology (128 citations), Genetics (47 citations) and Pathology and Forensic Medicine (69 citations). Sylvain Lamure has collaborated with scholars based in France, Germany and Italy. Frequent co-authors include Guillaume Cartron, Laura Platon, Xavier Ayrignac, Catherine Thiéblemont, Cathérine Belin, Perrine Devic, Rénata Ursu, Florent Wallet, Benoît Tessoulin and Élie Azoulay. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, EClinicalMedicine and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.